Skip to main content
. Author manuscript; available in PMC: 2014 Sep 15.
Published in final edited form as: Cochrane Database Syst Rev. 2010 Jul 7;(7):CD006865. doi: 10.1002/14651858.CD006865.pub2
Adverse events Withdrawals
Study ID Treatment Any Serious Adverse event Other
Chan 2005 (1) lumiracoxib 400 mg, n=60
(2) naproxen 500 mg, n=60
(3) placebo, n=60		 no single dose data None None None
Fricke 2008 (1) lumiracoxib 400 mg, n = 156
(2) celecoxib 400 mg, n = 156
(3) placebo, n = 52		 (1) 18/156
(3) 9/52		 None None None
Kellstein 2004 (1) lumiracoxib 400 mg, n=101
(2) rofecoxib50mg, n=102
(3) celecoxib 200mg, n=101
(4) placebo, n=51		 (1) 21/101
(4) 9/51		 None None None
Zelenekas 2004 (1) lumiracoxib 400 mg, n=50
(2) Ibuprofen 400 mg, n=51
(3) placebo, n=50		 (1) 1/50
(3) 10/50		 (1) 0/50
(3) 1/50 (DVT)		 (1) 0/50
(2) 1/51
(3) 0/50		 None